Journals / Ulusal Travma ve Acil Cerrahi Dergisi / 2013 / Cilt: 19 - Sayı: 1

Forrest tip 2b duodenal ülserlerde profilaktik enjeksiyon tedavisi gereklidir

Prophylactic injection therapy is necessary for Forrest type 2b duodenal ulcers

Pages
29–32
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: We recommend prophylactic injection therapy in patients with upper gastrointestinal bleeding who have Forrest type 2b duodenal ulcer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To assess the effect of prophylactic injection therapy during the index gastroscopy on upper gastrointestinal bleeding due to Forrest type 2b duodenal ulcer.
📊
Key Findings & Data:Methods: The patients who were admitted with upper gastrointestinal bleeding and who had emergency gastroscopy between January 2004 and January 2011 were retrospectively recruited to the study.
💡
Conclusion & Impact:Conclusion: We recommend prophylactic injection therapy in patients with upper gastrointestinal bleeding who have Forrest type 2b duodenal ulcer.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To assess the effect of prophylactic injection therapy during the index gastroscopy on upper gastrointestinal bleeding due to Forrest type 2b duodenal ulcer. Methods: The patients who were admitted with upper gastrointestinal bleeding and who had emergency gastroscopy between January 2004 and January 2011 were retrospectively recruited to the study. Among those, the patients with Forrest type 2b duodenal ulcer were selected and divided into two groups. The patients in Group 1 had only diagnostic gastroscopy, whereas those in Group 2 had prophylactic injection therapy during the index gastroscopy. Results: Eighty seven patients were included to the study. There were 41 patients in Group 1 and 46 patients in Group 2. There was a significant difference in the incidence of rebleeding (26.8% versus 6.5%, p=0.017). The mortality rate was similar in both groups (9.7% versus 2.1%, p=0.184). Conclusion: We recommend prophylactic injection therapy in patients with upper gastrointestinal bleeding who have Forrest type 2b duodenal ulcer.

Özet

AMAÇ Bu çalışmada Forrest tip 2b duodenal ülserlerde ilk endos- kopi işlemi esnasında yapılan profilaktik enjeksiyon teda- visinin ülserin tekrar kanama oranı üzerine etkisinin belir- lenmesi amaçlandı. GEREÇ VE YÖNTEM Çalışmaya hastanemizde 2004-2011 yılları arasında üst gastrointestinal sistem kanaması nedeniyle yapılan acil endoskopilerinde Forrest tip 2b duodenal ülser belirlenmiş hastalar alındı. Olgular rastgele olmayan iki gruba ayrıldı. Birinci gruba yalnızca tanısal endoskopi yapılan hastalar ve ikinci gruba tanısal endoskopiye ek olarak profilaktik enjeksiyon tedavisi yapılan hastalar alındı. Çalışmadaki birincil sonuç ölçütleri yeniden kanama ve ölüm oranı idi. BULGULAR Çalışmaya 87 hasta alındı. Bunlardan 41’i birinci, 46’sı ikin- ci grupta idi. Tekrar kanama oranı açısından her iki grup ara- sında anlamlı fark saptanırken (%26,8 ve %6,5, p=0,017), ölüm oranı açısından iki grup arasında istatistiksel anlam taşıyan bir farklılık gözlenmedi (%9,5 ve %2,1, p>0,05). SONUÇ Yeniden kanama riskini anlamlı düzeyde azalttığı için, For- rest tip 2b duodenal ülserlerde profilaktik enjeksiyon teda- visi uygulanmalıdır.

🔖

Cite This Article

ÖNER, O. Z., GÖNENÇ, M., KALAYCI, M. U., BOZKURT, M. A., KAPAN, S., ALIŞ, H. (2013). Forrest tip 2b duodenal ülserlerde profilaktik enjeksiyon tedavisi gereklidir. Ulusal Travma ve Acil Cerrahi Dergisi, Cilt: 19 - Sayı: 1, 29–32. https://ajindex.com/articles/324136

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Courtney AE, Mitchell RM, Rocke L, Johnston BT. Proposed risk stratification in upper gastrointestinal haemorrhage: is hospitalisation essential? Emerg Med J 2004;21:39-40
  2. Schemmer P, Decker F, Dei-Anane G, Henschel V, Buhl K, Herfarth C, et al. The vital threat of an upper gastrointestinal bleeding: Risk factor analysis of 121 consecutive patients. World J Gastroenterol 2006;12:3597-601
  3. Kim BJ, Park MK, Kim SJ, Kim ER, Min BH, Son HJ, et al. Comparison of scoring systems for the prediction of out- comes in patients with nonvariceal upper gastrointestinal bleeding: a prospective study. Dig Dis Sci 2009;54:2523-9
  4. Chen IC, Hung MS, Chiu TF, Chen JC, Hsiao CT. Risk scor- ing systems to predict need for clinical intervention for pa- tients with nonvariceal upper gastrointestinal tract bleeding.Am J Emerg Med 2007;25:774-9
  5. Cannistrà F. Emergency endoscopic treatment of digestive hemorrhages of the gastroduodenal tract (Forrest 1a, 1b). [Ar- ticle in Italian] Minerva Gastroenterol Dietol 1996;42:121-6. [Abstract] 6. Schröders CP, Glutig H, Frieling T, Imhof M, Röher HD. Ulcer hemorrhage: is aggressive surgical therapy still defen- sible?. [Article in German] Langenbecks Arch Chir Suppl Kongressbd 1997;114:1191-3. [Abstract] 7. Charatcharoenwitthaya P, Pausawasdi N, Laosanguaneak N, Bubthamala J, Tanwandee T, Leelakusolvong S. Character- istics and outcomes of acute upper gastrointestinal bleeding after therapeutic endoscopy in the elderly. World J Gastroen- terol 2011;17:3724-32
  6. Barkun A, Bardou M, Marshall JK; Nonvariceal Upper GI Bleeding Consensus Conference Group. Consensus recom- mendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003;139:843-57
  7. Saltzman JR, Tabak YP, Hyett BH, Sun X, Travis AC, Jo- hannes RS. A simple risk score accurately predicts in-hospi- tal mortality, length of stay, and cost in acute upper GI bleed- ing. Gastrointest Endosc 2011;74:1215-24
  8. Buffoli F, Graffeo M, Nicosia F, Gentile C, Cesari P, Rolfi F, et al. Peptic ulcer bleeding: comparison of two hemostatic procedures. Am J Gastroenterol 2001;96:89-94
  9. Parente F, Anderloni A, Bargiggia S, Imbesi V, Trabucchi E, Baratti C, et al. Outcome of non-variceal acute upper gastro- intestinal bleeding in relation to the time of endoscopy and the experience of the endoscopist: a two-year survey. World J Gastroenterol 2005;11:7122-30
  10. Kahi CJ, Jensen DM, Sung JJ, Bleau BL, Jung HK, Eckert G, et al. Endoscopi